Trial intelligence / Profile preview

Paclitaxel, Carboplatin and Low Dose Radiation in SCCHN

NCT00176267Phase 2Completed

Start
Sep 2002
Primary completion
Jan 2005
Modality
DNA Intercalators/Alkylators, Cytokines & Interferons, Fc-Fusion Proteins
01

Overview

A Phase 2 trial of Paclitaxel Micelles for Injection, carboplatin in squamous cell carcinoma of the head and neck (HNSCC). Started Sep 2002; status: completed.

02

Drugs

Paclitaxel Micelles for Injectioncarboplatin
03

Conditions

squamous cell carcinoma of the head and neck (HNSCC)

Beyond the preview

Go deeper on NCT00176267.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT00176267.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call